Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 10 | +10 |
| Shares | 0 | 260.3K | +260.3K |
| Value | $0 | $575.0K | +$575.0K |
New holders (10)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 80,000 | $177.0K | 0.00% |
| Jane Street Group, LLC | 62,200 | $137.0K | 0.00% |
| Ayrton Capital LLC | 60,525 | $134.0K | 0.13% |
| Perkins Capital Management Inc | 23,750 | $52.0K | 0.04% |
| Susquehanna International Group, LLP | 22,701 | $50.0K | 0.00% |
| Levin Capital Strategies, L.P. | 10,000 | $22.0K | 0.00% |
| US Bancorp | 1,000 | $2.00K | 0.00% |
| IFP Advisors, Inc | 75 | $1.00K | 0.00% |
| Pittenger & Anderson Inc | 1 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 14 | $0 | 0.00% |
Sold out (0)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.